Product

EttaFlow Flow Electroporation System​

EttaFlow Flow Electroporation System​

The EttaFlow Flow Electroporation System employs continuous-flow electroporation technology, breaking through the throughput limitations of traditional batch electroporators with a processing capacity of 1×10⁷–1×10¹⁰ cells per minute. Its patented flow chamber design combined with adjustable pulse parameters (voltage: 50–3000V, pulse width: 10μs–100ms)

Price:Negotiable

Service charge: 10% of the transaction price

  • Equipment brand:EttaFlow 
  • Equipment installation time:2022-9-7
  • Equipment location:China Shanghai
  • Equipment modelEBXP-F1
  • Equipment serial number20-EX=BSOF1-051
  • Voltage210-240 VAC (Output voltage30 - 600 VDC
  • Electrical frequency
  • SizeLength 623 × Width 452 × Height 325 mm
  • Weight28 kg

Device built-in

EttaFlow Flow Electroporation System Product Introduction

Core Technological Innovations
The EttaFlow Flow Electroporation System employs continuous-flow electroporation technology, breaking through the throughput limitations of traditional batch electroporators with a processing capacity of 1×10⁷–1×10¹⁰ cells per minute. Its patented flow chamber design combined with adjustable pulse parameters (voltage: 50–3000V, pulse width: 10μs–100ms) achieves 75–95% transfection efficiency for primary cells (e.g., T cells) while maintaining >85% viability, delivering 3x higher throughput than conventional methods.

Key Technical Features

  1. Closed Sterile Flow Path:

    • Disposable fluidic cartridges integrate electrodes and sample channels to prevent cross-contamination, meeting GMP-grade cell therapy production requirements
    • Operates at ambient temperatures from -4°C to 40°C, suitable for temperature-sensitive nucleic acid delivery (e.g., mRNA vaccines)
  2. Intelligent Parameter Optimization:

    • Preloaded programs for 20 cell types (CHO, HEK293, etc.)
    • Real-time impedance feedback automatically adjusts electric field strength (<2% pulse energy deviation)
  3. Multi-Application Adaptability:

    • Expandable configurations for CRISPR RNP, plasmid DNA, and mRNA-specific cartridges
    • Compatible with cell densities ranging from 2×10⁵ to 1×10¹¹ cells/mL

Primary Applications

  • Cell Therapy: CAR-T/NK cell engineering (>80% transfection efficiency, >90% viability)
  • Vaccine Development: Primary dendritic cell transfection for mRNA-LNP formulations (throughput up to 5×10⁹ cells/hour)
  • Industrial Microbiology: Genome editing in E. coli/yeast (40% higher efficiency than cuvette methods)
  • Gene Therapy: Suspension HEK293 transfection for AAV vector production

System Configuration

  • Main Unit: 21-inch touchscreen with CFR 21 Part 11-compliant data traceability
  • Consumables: 1 mL/5 mL/20 mL fluidic cartridges (50–200 transfections per cartridge)
  • Expansion Modules: Optional low-temperature (4°C) or high-throughput (96-well adapter) components

ISO 13485 certified, this system has been adopted by companies like Fosun Kite for commercial CAR-T production. The 2025 base model (including 5 cartridges) is priced at approximately ¥1.2–1.5 million RMB. Its compact footprint (45×60 cm) is ideal for Grade B+A cleanroom deployment.

(Note: "EttaFlow" is a registered trademark. Performance data based on primary T-cell validation studies.)


For application-specific protocols or cartridge selection guidance, please contact your regional distributor.


Email:newlife@yinzhisci.com

Tel:021-65381707